Globus Medical raises 2026 EPS guidance to $4.40-$4.50 with margin gains following record Q4 results

Q4 2025 earnings call recap: revenue/EPS beats, margin expansion, Nevro integration, and raised 2026 guidance—read key takeaways.
Harvard Business Review

Rethinking Strategy in a Hyperpolitical World

In an era of intensifying polarization, the boundary between business and politics has effectively vanished, rendering ...

Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsBrian Kearns - Senior Vice President of ...

Five Trends For Achieving Successful Corporate Governance In The 2026 Proxy Season

During proxy season, leadership must be clearly reflected in the proxy statement—both in what the company declares, and also how the board oversees and makes decisions.

Reframing The Agenda: Five Keys To Successful Transformation Efforts

There's no award for being first to adopt a new AI model—and no reward for an expensive transformation program that fails to ...